(October 17, 2016, 12:20 PM EDT) -- Recent securities class action and shareholder derivative lawsuits filed in federal courts across the country include complaints alleging misrepresentation of clinical trial results for a bladder cancer treatment drug, growth in key primary user metrics used to determine user engagement for Twitter Inc. and a surgical device company’s alleged concealment of deficiencies with regard to its “internal controls over financial reporting.”...